Connor Clark & Lunn Investment Management Ltd. Makes New $4.41 Million Investment in Accendra Health, Inc. $ACH

Connor Clark & Lunn Investment Management Ltd. purchased a new stake in shares of Accendra Health, Inc. (NYSE:ACH) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,288,787 shares of the company’s stock, valued at approximately $4,408,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the company. Keybank National Association OH purchased a new stake in shares of Accendra Health in the first quarter worth $46,000. Strs Ohio bought a new stake in Accendra Health during the 1st quarter valued at approximately $413,000. Abel Hall LLC purchased a new position in shares of Accendra Health in the first quarter worth $44,000. Hsbc Holdings PLC purchased a new stake in Accendra Health in the 1st quarter worth $34,000. Finally, Bank of New York Mellon Corp purchased a new stake in shares of Accendra Health in the first quarter worth about $592,000.

Analyst Upgrades and Downgrades

ACH has been the topic of several recent research reports. UBS Group decreased their target price on shares of Accendra Health from $4.50 to $1.50 and set a “neutral” rating on the stock in a research report on Thursday, August 13th. Weiss Ratings downgraded shares of Accendra Health from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, August 6th. Citigroup downgraded shares of Accendra Health from a “buy” rating to a “neutral” rating and decreased their price objective for the stock from $4.50 to $1.50 in a research note on Monday, August 10th. Finally, Robert W. Baird set a $1.50 target price on Accendra Health and gave the company a “neutral” rating in a research report on Tuesday, August 11th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, Accendra Health has an average rating of “Reduce” and a consensus target price of $1.50.

Accendra Health Stock Down 0.4%

Shares of NYSE ACH opened at $1.22 on Friday. Accendra Health, Inc. has a 52-week low of $0.93 and a 52-week high of $5.69. The stock has a market capitalization of $93.43 million, a price-to-earnings ratio of -0.31 and a beta of 1.58. The company has a 50 day moving average price of $2.72.

Accendra Health (NYSE:ACH) last released its quarterly earnings data on Monday, August 10th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by ($0.06). The firm had revenue of $613.23 million for the quarter. Accendra Health had a negative return on equity of 4.02% and a negative net margin of 11.41%. Equities research analysts anticipate that Accendra Health, Inc. will post -0.03 earnings per share for the current year.

Accendra Health Profile

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services.